Phosphodiesterase 5 inhibitors for Raynaud's phenomenon
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Phosphodiesterase 5 Inhibitors for Raynaud's Phenomenon." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/_________Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon______.
Phosphodiesterase 5 inhibitors for Raynaud's phenomenon. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/_________Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon______. Accessed April 20, 2025.
Phosphodiesterase 5 inhibitors for Raynaud's phenomenon. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/_________Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon______
Phosphodiesterase 5 Inhibitors for Raynaud's Phenomenon [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/_________Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phosphodiesterase 5 inhibitors for Raynaud's phenomenon
ID - 1305541
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/_________Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -